Levonorgestrel Impurity 9(61921-57-1)
- Name: Levonorgestrel Impurity 9
- Synonyms:18,19-Dinorpregna-4,16-dien-20-yn-3-one, 13-ethyl- (9CI);16(17)-Dehydro Levonorgestrel;Levonorgestrel Impurity 9
- Molecular Formula:C21H26O
- Molecular Weight:294.43
- CAS Registry Number:61921-57-1
- EINECS:
- Melting Point:429.7±45.0 °C(Predicted)
- Water Solubility:
Other Product
- 618884-98-3/5H-Indeno[1,2-b]pyridin-4-ol
- 618885-98-6/β-Alanine, N-(2-carboxyethyl)-N-[3-(decyloxy)propyl]-, monopotassium salt (9CI)
- 618902-12-8/[6-hydroxy-7-[6-hydroxy-2-(4-hydroxyphenyl)-3-[4-(2-piperidin-1-ylethoxy)benzoyl]-1-benzothiophen-7-yl]-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone
- 618902-67-3/Pyridinium, 4-[(dimethylamino)carbonyl]-1-sulfo-, inner salt
- 618907-10-1/Undecanedioic acid, compd. with 2-amino-2-methyl-1-propanol (1:2)
- 618913-16-9/3-isobutyl-2-thioxo-2,3-dihydro-1H-purin-6(7H)-one
- 618913-28-3/6H-Purin-6-one, 1,2,3,9-tetrahydro-3-[(4-methoxyphenyl)methyl]-2-thioxo-
- 618913-68-1/4(1H)-Pyrimidinone, 6-amino-2,3-dihydro-1-(2-phenylethyl)-2-thioxo-
- 61893-75-2/α-D-Galactopyranoside, 2,3-dibromopropyl 3-O-(2,3-dibromopropyl)-2,6-bis-O-(phenylmethyl)-, benzoate (9CI)
- 61893-76-3/α-D-Galactopyranoside, 2,3-dibromopropyl 3-O-methyl-2,6-bis-O-(phenylmethyl)-, benzoate (9CI)
- 61902-42-9/C.I. Solvent Yellow 110
- 61902-46-3/Benzamide, N-(5,6,12,17,18,24-hexahydro-5,12,17,24-tetraoxodinaphth[2,3-i:2',3'-i']indeno[4,3-ab:2,1-c']dicarbazol-23-yl)-
- 6190-41-6/D-Gluconic acid, 4-O-β-D-galactopyranosyl-, calcium salt, hydrate (2:1:5)
- 61-90-6/L-LeucineForBiochemistry99+%
- 6190-60-9/Sulfate dihydrate
- 6191-05-5/2-Thiophenepropanoic acid, 4,5-dimethyl-
- 61913-36-8/N2-tert-Butoxycarbonyl-[1,8-cyclo-[L-seryl-L-asparaginyl-L-leucyl-L-seryl-L-threonyl]cystyl]-L-valyl-L-leucyl-glycyl-N6-tert-butoxycarbonyl-L-lysyl-L-leucyl-L-seryl-N2-L-glutaminyl-(.gamma.-tert-butoxy-L-glutamoyl)-L-leucyl-N2-L-histidyl-N6-tert-butoxycarbonyl-L-lysyl-L-leucyl-N2-L-glutaminyl-L-threonyl-L-tyrosyl-L-prolyl-N2-L-arginyl-L-threonyl-N2-L-asparaginyl-L-threonyl-glycyl-L-seryl-L-glycyl-L-threonyl-L-prolinamide
- 61914-45-2/Cyclopropanecarboxylic acid, 3-[(1E)-2-chloroethenyl]-2,2-dimethyl-, (1R,3S)-rel-
- 6191-95-3/Propanamide, 3,3-diethoxy-N-ethyl-
- 61921-57-1/Levonorgestrel Impurity 9
- 61928-99-2/5H-Cyclopentapyrazin-5-ol, 6,7-dihydro-
- 619294-37-0/JWH 184
- 619296-83-2/Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(6-O-β-D-glucopyranosyl-β-D-glucopyranosyl)oxy]-5,8,8a,9-tetrahydro-5-(3,4,5-trimethoxyphenyl)-, (5R,5aS,8aR,9R)-
- 61930-05-0/Acetic acid, [[[(3β)-3-(sulfooxy)androst-5-en-17-ylidene]amino]oxy]- (9CI)
- 61931-73-5/D-Glucose, ethoxylated
- 619320-40-0/3-Aminodihydro-d2-2(3H)-thiophenone-4,5-d2
- 619323-98-7/(1''S)-4',5',5'',6''-Tetramethyl-[1,1':3',1'':3'',1'''-quaterphenyl]-2',2''-diol
- 619328-59-5/3-Pyridazinecarboxylic acid, 1,4-dihydro-6-methyl-4-oxo-1-[2-(trifluoromethyl)phenyl]-
- 619329-63-4/Benzamide, 4-(3-bromopropoxy)-
- 619331-37-2/1,2-Ethanedione, 1-(7-bromo-4-fluoro-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-[(2R)-2-methyl-4-(2-pyridinylcarbonyl)-1-piperazinyl]-